Literature DB >> 7983755

Functional analysis of the two alternative translation initiation sites of foot-and-mouth disease virus.

X Cao1, I E Bergmann, R Füllkrug, E Beck.   

Abstract

The effect of deletion of each of the two authentic polyprotein translation initiation sites of foot-and-mouth disease virus on viral protein synthesis and replication was analyzed. Deletion of either the first or the second initiation site led to the expression of only one form of the leader protein, L or L', respectively, but in vitro processing of the viral polyprotein and cleavage of eIF-4 gamma were not affected by either deletion. Whereas RNA in which the first translation initiation site had been deleted led to the production of viruses in transfected BHK cells, deletion of the second translation initiation site abolished virus replication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7983755      PMCID: PMC188610          DOI: 10.1128/JVI.69.1.560-563.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs.

Authors:  D V Sangar; S E Newton; D J Rowlands; B E Clarke
Journal:  Nucleic Acids Res       Date:  1987-04-24       Impact factor: 16.971

2.  A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.

Authors:  R Higuchi; B Krummel; R K Saiki
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

3.  A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation.

Authors:  S K Jang; H G Kräusslich; M J Nicklin; G M Duke; A C Palmenberg; E Wimmer
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

4.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

5.  Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220.

Authors:  H G Kräusslich; M J Nicklin; H Toyoda; D Etchison; E Wimmer
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

6.  A second protease of foot-and-mouth disease virus.

Authors:  K Strebel; E Beck
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

7.  Nucleotide sequence and genome organization of foot-and-mouth disease virus.

Authors:  S Forss; K Strebel; E Beck; H Schaller
Journal:  Nucleic Acids Res       Date:  1984-08-24       Impact factor: 16.971

8.  Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex.

Authors:  D Etchison; S C Milburn; I Edery; N Sonenberg; J W Hershey
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

9.  Structure of the FMDV translation initiation site and of the structural proteins.

Authors:  E Beck; S Forss; K Strebel; R Cattaneo; G Feil
Journal:  Nucleic Acids Res       Date:  1983-11-25       Impact factor: 16.971

10.  Two initiation sites for foot-and-mouth disease virus polyprotein in vivo.

Authors:  B E Clarke; D V Sangar; J N Burroughs; S E Newton; A R Carroll; D J Rowlands
Journal:  J Gen Virol       Date:  1985-12       Impact factor: 3.891

View more
  23 in total

1.  Construction of regulatable picornavirus IRESes as a test of current models of the mechanism of internal translation initiation.

Authors:  T A Pöyry; M W Hentze; R J Jackson
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

Review 2.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

3.  Mechanisms governing the selection of translation initiation sites on foot-and-mouth disease virus RNA.

Authors:  Tuija A A Pöyry; Richard J Jackson
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

4.  Translation initiation factor eIF4B interacts with a picornavirus internal ribosome entry site in both 48S and 80S initiation complexes independently of initiator AUG location.

Authors:  K Ochs; R C Rust; M Niepmann
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  The properties of chimeric picornavirus IRESes show that discrimination between internal translation initiation sites is influenced by the identity of the IRES and not just the context of the AUG codon.

Authors:  T Ohlmann; R J Jackson
Journal:  RNA       Date:  1999-06       Impact factor: 4.942

6.  A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function.

Authors:  Teresa de los Santos; Fayna Diaz-San Segundo; James Zhu; Marla Koster; Camila C A Dias; Marvin J Grubman
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

7.  A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals.

Authors:  Sabena Uddowla; Jason Hollister; Juan M Pacheco; Luis L Rodriguez; Elizabeth Rieder
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

8.  Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers.

Authors:  Ariel Vagnozzi; David A Stein; Patrick L Iversen; Elizabeth Rieder
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

9.  Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection.

Authors:  Teresa de Los Santos; Fayna Diaz-San Segundo; Marvin J Grubman
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

10.  Residue L143 of the foot-and-mouth disease virus leader proteinase is a determinant of cleavage specificity.

Authors:  Christina Mayer; David Neubauer; Aloysius T Nchinda; Regina Cencic; Katja Trompf; Tim Skern
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.